Article

Unusual immunophenotype of CD8+ T cells in familial hemophagocytic lymphohistiocytosis.

Department of Pathology, The University of Texas Southwestern Medical Center at Dallas, 75390-9072, USA.
Blood (Impact Factor: 9.78). 11/2004; 104(7):2007-9. DOI: 10.1182/blood-2004-04-1431
Source: PubMed

ABSTRACT Familial hemophagocytic lymphohistiocytosis (FHL) is an inherited, fatal disorder of infancy. We report here a 17-day-old female infant who presented with high fever, hepatosplenomegaly, hypertriglyceridemia, hypofibrinogenemia, thrombocytopenia, and liver failure. Leukocytosis was detected with circulating "atypical" lymphoid cells. Flow cytometric studies revealed expanded subpopulations of CD8+ T cells with unusual immunophenotypic features, including a subset that lacked CD5 expression. A liver biopsy showed hemophagocytic lymphohistiocytosis with exuberant infiltrates of CD8+ T cells that lacked perforin. Mutational studies revealed a 666C-->A (H222Q) missense mutation in the perforin gene. T-cell receptor studies on flow-sorted T-cell subpopulations revealed no evidence of monoclonality. Analysis of T-cell receptor excision circle levels indicated long proliferative history in the aberrant CD8+ T-cell subsets. This case provides an instructive example of uncontrolled reactive proliferation of CD8+ T cells in FHL, resulting in atypical morphology and unusual immunophenotypic features that might suggest malignancy in other clinical settings.

0 Bookmarks
 · 
100 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hemophagocytic lymphohistiocytosis (HLH) is characterized by uncontrolled activation of T cells and macrophages with overproduction of cytokines. Familial HLH type2 (FHL2) is the most common form of primary HLH and is caused by mutations in PRF1. We have recently described a significant increase in the subpopulation of CD8(+) T cells with clonal expansion and CD5 down-regulation in Epstein-Barr virus associated-HLH, which represented a valuable tool for its diagnosis. However, this unusual phenotype of CD8(+) T cells has not been investigated fully in patients with FHL2. We performed immunophenotypic analysis of peripheral blood and measured serum pro-inflammatory cytokines in 5 patients with FHL2. All patients showed significantly increased subpopulations of activated CD8(+) T cells with down-regulation of CD5, which were negligible among normal controls. Analysis of T-cell receptor Vβ repertoire suggested the reactive and oligoclonal expansion of these cells. The proportion of the subset declined after successful treatment concomitant with reduction in the serum levels of cytokines in all patients except one who continued to have a high proportion of the subset and died. These findings suggest that down-regulation of CD5 on activated CD8(+) T cells may serve as a useful marker of dysregulated T cell activation and proliferation in FHL2.
    Human immunology 09/2013; DOI:10.1016/j.humimm.2013.09.001 · 2.55 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Histiocytic disorders are diseases characterized by the proliferation and/or accumulation of histocytic cells in bone marrow (BM), peripheral blood (PB), and a variety of extramedullary tissues, associated with variable local and systemic symptoms, which depend on the disease subtype. Histiocytes are hematopoietic cells that derive from BM progenitors and have important functions in the immune system, including antigen presentation and antigen processing. Normal histiocytes include multiple functional subsets with distinct morphology, immunophenotype, and tissue localization. Histiocytic dis-orders are currently classified according to their morphologic and immunophenotypic resemblance to these normal counterparts, as well as according to their clinical presentation and biologic behavior (Table 42.1). The immunohistochemical classification of the tumors of histiocytes and accessory dendritic cells proposed by the International Lymphoma Study Group comprises two major categories: disorders of varied biologic behavior and malignant disorders. This chapter will focus on the former category, which includes clonal and non-clonal entities, none of which may be definitively classified as malignant, although their clinical behavior may be aggressive and even fatal (Table 42.2). The malignant disorders include sarcomas with histiocytic or dendritic cell differentiation, as well as acute myeloid leukemias (AMLs) with monocytic or monoblastic differentiation. Due to the rarity and thus lack of a significant amount of molecular data, sarcomas with histiocytic or dendritic cell differentiation will not be addressed in this chapter. For a discussion of AMLs with monocytic or monoblastic differentiation, see Chaps. 34 and 35.
  • Source
    Annals of Laboratory Medicine 01/2015; 35(1):155-8. DOI:10.3343/alm.2015.35.1.155 · 1.48 Impact Factor

Full-text (2 Sources)

Download
51 Downloads
Available from
Jun 1, 2014